UBS AM’s Arcellx ACLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-57,289
| Closed | -$6.58M | – | 3724 |
|
|
2026
Q1 | $6.58M | Sell |
57,289
-103,746
| -64% | -$9.16M | ﹤0.01% | 1425 |
|
|
2025
Q4 | $10.5M | Sell |
161,035
-7,596
| -5% | -$606K | ﹤0.01% | 1102 |
|
|
2025
Q3 | $13.8M | Sell |
168,631
-98,480
| -37% | -$7.09M | ﹤0.01% | 961 |
|
|
2025
Q2 | $17.6M | Buy |
267,111
+2,355
| +0.9% | +$147K | ﹤0.01% | 1101 |
|
|
2025
Q1 | $17.4M | Sell |
264,756
-2,628
| -1% | -$178K | ﹤0.01% | 1012 |
|
|
2024
Q4 | $20.5M | Sell |
267,384
-15,471
| -5% | -$1.34M | ﹤0.01% | 934 |
|
|
2024
Q3 | $23.6M | Sell |
282,855
-27,527
| -9% | -$1.83M | 0.01% | 887 |
|
|
2024
Q2 | $17.1M | Buy |
310,382
+44,972
| +17% | +$2.44M | ﹤0.01% | 921 |
|
|
2024
Q1 | $18.5M | Buy |
265,410
+135,274
| +104% | +$8.58M | 0.01% | 814 |
|
|
2023
Q4 | $7.22M | Sell |
130,136
-55,457
| -30% | -$2.5M | ﹤0.01% | 1109 |
|
|
2023
Q3 | $6.66M | Buy |
185,593
+168,993
| +1,018% | +$5.83M | ﹤0.01% | 1112 |
|
|
2023
Q2 | $511K | Hold |
16,600
| – | – | ﹤0.01% | 2311 |
|
|
2023
Q1 | $511K | Buy |
16,600
+2,900
| +21% | +$88K | ﹤0.01% | 2311 |
|
|
2022
Q4 | $424K | Buy |
+13,700
| New | +$314K | ﹤0.01% | 2238 |
|
Other funds holding ACLX
UBS AM's ACLX Position: Q2 2026 in Review
UBS AM sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 57,289 shares — an estimated $6.58M sold.
UBS AM first reported a position in ACLX in Q4 2022 and held it in 14 quarters. The position peaked at $23.6M in Q3 2024. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.
- UBS AM reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
- UBS AM sold 57,289 Arcellx shares in Q2 2026, an estimated $6.58M.
- UBS AM first reported a position in Arcellx in Q4 2022 and held it in 14 quarters.
- UBS AM's Arcellx position peaked at $23.6M in Q3 2024.
- 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.